| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. | J Med Chem | 2008 | 5.15 |
| 2 | Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity. | J Med Chem | 2009 | 0.86 |
| 3 | Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2. | Bioorg Med Chem Lett | 2008 | 0.84 |
| 4 | Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents. | Eur J Pharmacol | 2005 | 0.82 |
| 5 | Identification of potent 11mer glucagon-like peptide-1 receptor agonist peptides with novel C-terminal amino acids: Homohomophenylalanine analogs. | Peptides | 2010 | 0.79 |